SOURCE: Spencer Pharmaceutical, Inc.

November 30, 2010 09:00 ET

Spencer Pharmaceutical Announces Postponement of the Dinner Honouring Al-Dorra

BOSTON, MA--(Marketwire - November 30, 2010) - Spencer Pharmaceutical, Inc. (PINKSHEETS: SPPH) announced today that it has had to reschedule the dinner honouring Al-Dorra originally scheduled for today, Tuesday, November 30th and has rescheduled to Wednesday of next week (December 8th). Unfortunately, the Al-Dorra representatives are unable to be in Montreal for today's function. The details for the dinner next week remain the same (time and place). 

About Spencer Pharmaceutical, Inc.

Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.

Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.

Contact Information

  • Contact:
    Dr. Max Arella
    Spencer Pharmaceutical, Inc.
    Tel. 1+(617) 973-5017